Clinical Presentation and Frequency of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: An Experience From a Tertiary Care Hospital in Pakistan

Sarwat Anjum, Saima Askari, Musarrat Riaz, Abdul Basit, Sarwat Anjum, Saima Askari, Musarrat Riaz, Abdul Basit

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. The aim of this study was to determine the variations in the clinical presentation and frequency of metabolic syndrome (MetS) in women with PCOS.

Methods: This cross-sectional study was conducted at the Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan, from April 2019 to March 2020. Women attending the endocrine clinic who satisfied the Rotterdam criteria of PCOS and agreed to participate in the study were included. Detailed personal and family history of menstrual cycle, hirsutism, diabetes, hypertension, dyslipidemia and obesity was noted along with measurement of vitals, anthropometric measures and calculation of the body mass index. Physical examination performed for signs of hyperandrogenism, insulin resistance and biochemical and hormonal evaluation was also carried out in recruited participants. Statistical analysis was done using the Statistical Package for the Social Sciences (SPSS) version 20 (IBM Corp., Armonk, NY).

Results: A total of 153 participants with mean age of 27.2±8.13 years were included in this study. Regarding clinical presentation, menstrual irregularity (oligomenorrhea 39.85%, amenorrhea 38.9%), followed by hirsutism 52.3%, was the most common presentation. Polycystic appearance of ovaries was noted in 33.3% of our study participants. MetS was identified in 46.4% participants (obesity was noted at the highest frequency at 82.4% followed by dyslipidemia at 56.2%).

Conclusion: We observed a high frequency of MetS in females presenting with PCOS. There is a need to evaluate women with PCOS for various components of MetS to prevent potential complications.

Keywords: clinical presentation; metabolic syndrome; pcos.

Conflict of interest statement

The authors have declared that no competing interests exist.

Copyright © 2020, Anjum et al.

Figures

Figure 1. Frequency of metabolic syndrome in…
Figure 1. Frequency of metabolic syndrome in study participants
HDL, high-density lipoprotein; FBS, fasting blood sugar.
Figure 2. The components of metabolic syndrome…
Figure 2. The components of metabolic syndrome in family members of women with PCOS
PCOS, polycystic ovary syndrome.

References

    1. Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital based cross-sectional study from Eastern India. Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Indian J Endocrinol Metab. 2013;17:304–309.
    1. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 1. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. Endocr Pract. 2015;21:1291–1300.
    1. The polycystic ovary morphology - polycystic ovary syndrome spectrum. Rosenfield RL. J Pediatr Adolesc Gynecol. 2015;28:412–419.
    1. Metabolic syndrome, diet and exercise. De Sousa SM, Norman RJ. Best Pract Res Clin Obstet Gynaecol. 2016;37:140–151.
    1. Clinical characteristics of polycystic ovary syndrome in Indian women. Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Indian J Endocrinol Metab. 2013;17:138–145.
    1. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Wang R, Mol BW. Hum Reprod. 2017;32:261–264.
    1. Frequency of the metabolic syndrome in type 2 diabetic subjects attending the diabetes clinic of a tertiary care hospital. Imam SK, Shahid SK, Hassan A, Alvi Z. J Pak Med Assoc. 2007;57:239–242.
    1. Thyroid disease and female reproduction. Poppe K, Velkeniers B, Glinoer D. Clin Endocrinol (Oxf) 2007;66:309–321.
    1. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Cheung LP, Ma RC, Lam PM, et al. Hum Reprod. 2008;23:1431–1438.
    1. Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome. Romanowski MD, Parolin MB, Freitas AC, Piazza MJ, Basso J, Urbanetz AA. Arq Gastroenterol. 2015;52:117–123.
    1. Polycystic ovary syndrome and metabolic syndrome. Ali AT. Ceska Gynekol. 2015;80:279–289.
    1. Prevalence of metabolic syndrome in Pakistani women with polycystic ovarian syndrome. Anjum N, Zohra S, Arif A, Azhar A, Qureshi M. Pak J Biochem Mol Biol. 2013;46:97–100.
    1. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS. Bañuls C, Rovira-Llopis S, de Marañon AM, et al. Metabolism. 2017;71:153–162.
    1. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: a community-based study. Herrera-Enriquez K, Narvaez-Guerra O. Diabetes Metab Syndr. 2017;11:0.
    1. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN, PCOS/Troglitazone Study Group. J Clin Endocrinol Metab. 2006;91:48–53.
    1. Hypertriglyceridemic waist is associated with impaired glucose tolerance in polycystic ovary syndrome. Lerchbaum E, Schwetz V, Giuliani A, Obermayer-Pietsch B. Nutr Metab Cardiovasc Dis. 2013;23:0.
    1. Clinical and biochemical characteristics of polycystic ovary syndrome in Benghazi-Libya: a retrospective study. Najem F, Elmehdawi R, Swalem A. Libyan J Med. 2008;3:71–74.
    1. Endocrine correlates of polycystic ovary syndrome in Pakistani women. Akram M, Roohi N. . J Coll Physicians Surg Pak. 2015;25:22–26.
    1. Prevalence of thyroid dysfunction in patients with polycystic ovarian syndrome: a cross sectional study. Shanmugham D, Natarajan S, Karthik A. Int J Reprod Contracept Obstet Gynecol. 2018;7:3055–3059.
    1. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. Basit A, Fawwad A, Qureshi H, Shera AS, NDSP Members. BMJ Open. 2018;8:0.
    1. Subclinical hypothyroidism in PCOS: impact on presentation, insulin resistance, and cardiovascular risk. Yu Q, Wang JB. Biomed Res Int. 2016;2016:2067087.
    1. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome? Celik C, Abali R, Tasdemir N, Guzel S, Yuksel A, Aksu E, Yılmaz M. Gynecol Endocrinol. 2012;28:615–618.
    1. Obesity, arterial hypertension, metabolic disorders, and polycystic ovary syndrome. (Article in Spanish) Quiñónez CZ, Silva RR, Torres JJ. Ginecol Obstet Mex. 2000;68:317–322.
    1. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Legro RS, Kunselman AR, Dodson WC, Dunaif A. J Clin Endocrinol Metab. 1999;84:165–169.
    1. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y, Guo M, Yan J, et al. Neuro Endocrinol Lett. 2007;28:807–810.
    1. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome. Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C. Eur J Endocrinol. 2006;155:859–865.
    1. Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Zahiri Z, Sharami SH, Milani F, Mohammadi F, Kazemnejad E, Ebrahimi H, Heirati SF. Int J Fertil Steril. 2016;9:490–496.
    1. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Yilmaz B, Vellanki P, Ata B, Yildiz BO. Fertil Steril. 2018;109:356–364.
    1. Prevalence and clinical profile of insulin resistance in young women of poly cystic ovary syndrome: a study from Pakistan. Tabassum R, Imtiaz F, Sharafat S. Pak J Med Sci. 2013;29:593–596.
    1. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Adams J, Polson DW, Franks S. Br Med J (Clin Res Ed) 1986;293:355–359.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe